AKT1 and non-small cell lung carcinoma: Notably, in NCI-H460 cells, ophiopogonin B suppressed the PAM signaling pathway than in NCI-H157 cells, suggesting it as a potential inhibitor of the PI3K/AKT pathway for the treatment of NSCLC (Chen et al., 2013).